An Open-Label Extension Study Of Lamotrigine In Subjects With Bipolar Disorder

NCT00360126 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: lamotrigine

Sponsor

GlaxoSmithKline